HIV prevention policy: latest news

HIV prevention policy resources

HIV prevention policy features

HIV prevention policy news from aidsmap

More news

HIV prevention policy news selected from other sources

  • Dean Street clinics—battling London's MSM HIV epidemic

    Dean Street's success in managing those at risk of HIV infection is evident, with their clinics' new HIV diagnoses dropping from a peak of 72 cases in June 2015 to 11 in September 2017. But like other prevention services in the UK, the good work being done risks being undone by the continual cuts to the public health grant from central government that councils across England use to fund HIV and STI prevention.

    08 May 2018 | The Lancet HIV (requires free registration)
  • International AIDS Society Commitments in 2018

    An excerpt from the IAS annual letter in advance of the 22nd International AIDS Conference (AIDS 2018) in Amsterdam.

    26 April 2018 | Poz
  • Better ways to combat HIV than seeking a vaccine

    Are human-vaccine trials the best use of resources? Based on the current reality, HIV treatment and prevention strategies that have been proven to work would be a much better use of the millions of dollars being spent on the large-scale vaccine clinical trials.

    22 March 2018 | Business Day
  • Gay men seeking HIV-preventing PrEP drugs are being ‘turned away’ from sexual health clinics over trial capacity

    More than two dozen sexual health clinics in England are now turning away gay men who are seeking to take HIV-preventing drugs, PinkNews has found.

    21 March 2018 | Pink News
  • A daily pill can prevent HIV infections. Why don’t more people use it?

    Although millions of people around the world could benefit, only 200,000 are prescribed what’s called pre-exposure prophylaxis, or PrEP, and 75% of them are in the United States. “I’m frustrated,” says Linda-Gail Bekker, a researcher at the University of Cape Town in South Africa. “We have nearly 1700 infections every week in young women and girls, and this might be a way to throttle this.”

    13 March 2018 | Science
  • In the Era of Daily PrEP, Feds May Stop Research Funding Gels, Rings, and Douches for HIV Prevention

    It's precisely because of the overwhelming success in recent years of oral PrEP that the future of the anal douche and other sorts of topically applied anti-HIV agents, such as gels and dissolvable films, all loosely termed "microbicides," is suddenly up in the air, if not outright doomed.

    07 March 2018 | The Body
  • Empirical evidence that achievement of UNAIDS 90-90-90 can deliver promised HIV elimination?

    Researchers working on the Rakai Community Cohort Study in Uganda claim this is the first study to demonstrate the population level effect of the combination strategy for HIV prevention.

    19 December 2017 | BMJ Group blogs
  • CDC Reportedly Bans Words Including “Transgender” and “Science-Based”

    The Trump Administration is forbidding policy analysts at the nation’s main public health agency from using seven words and phrases, including transgender, fetus and evidence-based, in official documents dealing with the upcoming budget, The Washington Post reported. That assertion is a “complete mischaracterization of discussions,” says an HHS spokesperson.

    19 December 2017 | Poz
  • Australian Labor party commits to $53m plan to 'make HIV history'

    People at high risk of HIV would be given cheap access to a breakthrough preventative medicine under a federal Labor plan to make Australia the first nation in the world to win the fight against the virus that causes AIDS. The opposition's $53 million plan would dramatically expand state trials of the drug PrEP until it is approved for a federal subsidy, increase funding for HIV peak bodies and tackle rising transmission rates in Aboriginal communities.

    11 December 2017 | Sydney Morning Herald
  • Do HIV-Preventing Microbicides Have a Future in the Age of PrEP?

    Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.

    11 December 2017 | Poz
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.